As teachers experiment with ways to block students from cheating with generative AI, including going back to pen and paper, ...

Sanofi says that its experimental drug amlitelimab has the potential to become a ‘best-in-class’ maintenance therapy for atopic dermatitis (AD) after reporting new phase 2b data. The latest ...